Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

, AMPH

Amphastar

$21.90

0.1 (0.46%)

11:57
01/17/19
01/17
11:57
01/17/19
11:57
Recommendations
Emergent BioSolutions, Amphastar analyst commentary at Wells Fargo »

Wells says naloxone news…

EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

AMPH

Amphastar

$21.90

0.1 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

, AMPH

Amphastar

$21.91

0.11 (0.50%)

11:55
01/17/19
01/17
11:55
01/17/19
11:55
Hot Stocks
FDA commissioner describes efforts to support development of OTC naloxone »

FDA Commissioner Scott…

EBS

Emergent BioSolutions

$65.86

0.79 (1.21%)

AMPH

Amphastar

$21.91

0.11 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
AMPH

Amphastar

$19.72

-0.1 (-0.50%)

, CVS

CVS Health

$65.55

0.06 (0.09%)

06:02
01/03/19
01/03
06:02
01/03/19
06:02
Hot Stocks
Amphastar announces launch of Primatene MIST to nationwide retail pharmacies »

Pharmaceuticals (AMPH)…

AMPH

Amphastar

$19.72

-0.1 (-0.50%)

CVS

CVS Health

$65.55

0.06 (0.09%)

WBA

Walgreens Boots Alliance

$68.03

-0.31 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

Over a month ago
AMPH

Amphastar

$21.55

0.64 (3.06%)

, EBS

Emergent BioSolutions

$70.06

1.65 (2.41%)

11:13
11/16/18
11/16
11:13
11/16/18
11:13
Hot Stocks
Amphastar, Emergent on watch as 60 Minutes teases upcoming naloxone features »

Traders have circulated a…

AMPH

Amphastar

$21.55

0.64 (3.06%)

EBS

Emergent BioSolutions

$70.06

1.65 (2.41%)

OPNT

Opiant Pharmaceuticals

$15.60

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 02

    Dec

  • 12

    Dec

AMPH

Amphastar

$21.63

0.95 (4.59%)

16:29
11/09/18
11/09
16:29
11/09/18
16:29
Syndicate
Breaking Syndicate news story on Amphastar »

Amphastar files $250M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AMPH

Amphastar

$20.68

1.44 (7.48%)

16:47
11/08/18
11/08
16:47
11/08/18
16:47
Earnings
Amphastar reports Q3 adj. EPS 12c, consensus 11c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 27

    Nov

AMPH

Amphastar

$20.25

1.01 (5.25%)

09:53
11/08/18
11/08
09:53
11/08/18
09:53
Recommendations
Amphastar analyst commentary at Wells Fargo »

Amphastar inhaler…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 27

    Nov

AMPH

Amphastar

$19.70

0.46 (2.39%)

09:47
11/08/18
11/08
09:47
11/08/18
09:47
Hot Stocks
Amphastar announces FDA approves reintroduction of Primatene MIST »

Amphastar Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 27

    Nov

Over a quarter ago
AMPH

Amphastar

$17.21

-0.74 (-4.12%)

10:41
08/09/18
08/09
10:41
08/09/18
10:41
Recommendations
Amphastar analyst commentary at Wells Fargo »

Amphastar shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMPH

Amphastar

$17.95

0.16 (0.90%)

16:44
08/08/18
08/08
16:44
08/08/18
16:44
Earnings
Amphastar reports Q2 EPS 3c, consensus 7c »

Reports Q2 revenue $71M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.